Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.09 USD | +3.81% | -4.66% | -40.51% |
May. 06 | SAB Biotherapeutics, Inc. Appoints Jay Skyler, Md, to the Board of Directors | CI |
Apr. 16 | SAB Biotherapeutics, Inc. Provides SAB-142 Trial Update | CI |
Evolution of the average Target Price on SAB Biotherapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering SAB Biotherapeutics, Inc.
HC Wainwright | |
Ladenburg Thalmann | |
Chardan Research | |
Northland Securities | |
Chardan | |
Baird |
EPS Revisions
- Stock Market
- Equities
- SABS Stock
- Consensus SAB Biotherapeutics, Inc.